Cash figures as of 2026-06-30. Database snapshot: 2026-09-22.
Price history
Loading ANTX daily closes…
Loading price history…
Pipeline assets
Epetraborole
Phase 2 · ActiveModality: oral boron-based small molecule
Target LeuRS (leucyl-tRNA synthetase)
Partnerships Anacor Pharmaceuticals: exclusive worldwide license (boron chemistry compounds); Brii Biosciences: licensed-product rights in China, Hong Kong, Taiwan and Macau; NIAID: cost-reimbursement contract (up to $9.3M cumulative committed) supporting late-stage development
Indications
Polycythemia vera (phlebotomy-dependent)(Phase 2)
M. abscessus complex lung disease(Phase 2)
Acute systemic melioidosis and other biothreat pathogens(Preclinical)
Catalysts
— Q3 2026
— Q4 2026
Status note PV Phase 2 = sentinel + dose-optimization + randomized placebo-controlled parts, 40-50 pts, India. M. abscessus Phase 2 = investigator-initiated study with OHSU (IND cleared Dec 2025). Melioidosis Phase 2 proof-of-concept trial pending federal funding; NIAID contract options reduced $9.0M in June 2025 under a 2025 Executive Order cost-efficiency initiative.
AN2-502998
Phase 1 · ActiveModality: oral boron-based small molecule
Target CPSF3
Indications
Chagas disease(Phase 1)
Catalysts
— 2026
Status note Phase 1 first-in-human trial in healthy volunteers commenced August 2025; initial clinical data were expected Q1 2026 per the filing.
Per-asset detail extracted from the 10-Q filed 2026-08-11. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
Institutional holders
Fund
Shares
Q/Q change
% of portfolio
Filing
ADAR1 Capital Management
58,808
+44,947
0.01%
2026-08-14
Institutional holder positions from 13F filings. Q/Q change is vs the prior quarter's filing; % of portfolio is the fund's own reported portfolio weight.
Get the weekly biotech catalyst rundown. Cash runways, financings, and trial readouts for all 714 stocks.